The Nvidia Problem Nobody Saw Coming

Here's an interesting wrinkle in the AI chip wars: Alphabet Inc. (GOOG) just released a new version of Gemini that's outperforming OpenAI's latest ChatGPT on multiple benchmarks. That's good news for Google, obviously. But it creates a fascinating problem for NVIDIA Corp (NVDA).

The issue comes down to economics. Google is running Gemini on its own custom chips. ChatGPT runs on Nvidia's hardware. If Google can deliver superior AI performance at a lower compute cost than everyone else who's stuck buying Nvidia chips, we've got a serious competitive imbalance brewing. Companies using Nvidia chips will either lose market share to Google, or Nvidia will need to compress its profit margins to keep the playing field level. Neither outcome is great for Nvidia shareholders.

The silver lining for Google? This AI advantage might help them maintain their search dominance in an era when everyone assumed ChatGPT would eat their lunch.

Market Technical Picture Brightens

Looking at the SPDR S&P 500 ETF Trust (SPY), which tracks the S&P 500 index, the technical setup is actually looking pretty constructive. The market approached the upper band of its first support zone but hasn't dipped into it, which is a positive sign. The Relative Strength Index shows oversold conditions, and oversold markets typically bounce.

Here's where it gets interesting: trading models are now signaling it's time to deploy cash and reduce hedges. That's a notable shift in positioning.

Investors are latching onto hopes of a December rate cut following comments from New York Fed President John Williams on Friday. Never mind that other Federal Reserve officials aren't exactly singing the same tune. The market hears what it wants to hear, and right now it wants to hear "rate cut."

Add in positive seasonality—Thanksgiving week historically tends to be strong for equities—and you've got a recipe for optimism. At least in the near term.

Healthcare Stocks Make Big Moves

The healthcare sector is seeing some dramatic action on two separate fronts.

First, health insurers are soaring on speculation that President Trump will announce an extension of ObamaCare with some modifications. Centene Corp (CNC) and Oscar Health Inc (OSCR) are flying higher, along with industry giants UnitedHealth Group Inc (UNH) and Humana Inc (HUM). It's all based on rumor at this point, but the market is pricing in the probability.

On the flip side, we've got disappointing news from the weight-loss drug universe. A clinical trial showed that Ozempic did not slow Alzheimer's progression. That's hitting both Novo Nordisk A/S (NVO) and Eli Lilly And Co (LLY) stocks. The market had been pricing in the possibility that these GLP-1 drugs might have broader therapeutic applications beyond diabetes and weight loss. This trial result puts a dent in that thesis.

Magnificent Seven Money Flows Turn Positive

Given how concentrated most portfolios have become in the Magnificent Seven tech stocks, tracking their daily money flows has become essential for understanding broader market direction.

In early trading, money flows are positive across the entire cohort: Nvidia (NVDA), Amazon.com, Inc. (AMZN), Alphabet Inc. (GOOG), Meta Platforms Inc (META), Microsoft Corp (MSFT), Tesla Inc (TSLA), and Apple Inc (AAPL) are all seeing inflows.

The major index ETFs are following suit, with both S&P 500 ETF (SPY) and Invesco QQQ Trust Series 1 (QQQ) showing positive money flows in early trading.

What's On The Economic Calendar

Tomorrow at 8:30am ET, we'll get September Producer Price Index data and September retail sales figures. These releases will give markets fresh information about inflation pressures and consumer spending strength.

Bitcoin Consolidates

Bitcoin (BTC) remains range bound, consolidating recent gains without making a clear directional move.

Investment Strategy In Current Environment

The current setup suggests maintaining quality long-term positions while keeping appropriate protection levels based on individual risk tolerance. A combination of cash reserves or Treasury bills, along with tactical hedges, provides a way to participate in potential upside while managing downside risk.

Your protection band—the combination of cash and hedges—should reflect your age and risk profile. Conservative or older investors should lean toward the higher end of protection ranges. Younger or more aggressive investors can operate with less protection. If you're not using hedges, your cash allocation should be higher than if you are hedging, but still meaningfully less than the combined cash-plus-hedge level.

Think of the protection band on a scale from 0% to 100%. Zero percent would indicate full investment with maximum bullishness. One hundred percent would suggest maximum bearishness with aggressive hedging or short positions.

Here's something worth remembering: you can't take advantage of new opportunities if you're not holding adequate cash reserves. When you're adjusting hedge levels, consider using partial stop quantities on individual stock positions (not ETFs), employing wider stops on remaining positions, and giving high beta stocks—those that move more dramatically than the broader market—additional room to fluctuate.

A Note On Bond Allocation

For investors following the traditional 60/40 portfolio model (60% stocks, 40% bonds), the current environment doesn't favor long-duration strategic bond positions when you account for inflation-adjusted risk and reward probabilities.

If you're committed to maintaining that 40% bond allocation, focus on high-quality bonds with durations of five years or less. More sophisticated investors might consider treating bond ETFs as tactical positions rather than strategic core holdings in the current environment.

The bottom line: markets are getting some technical and seasonal tailwinds, but the AI chip competitive landscape just got a lot more interesting. Google's chip independence could reshape the economics of artificial intelligence infrastructure, and that has implications well beyond just Nvidia's stock price.